US OptionsDetailed Quotes

RXRX240719P2000

Watchlist

0.02
0.000.00%

15min DelayClose Jul 10 15:49 ET

0.00High0.00Low

Recursion Pharmaceuticals Stock Discussion

BucceesNation

Jun 29 23:52

RXRX 10% shareholder ARK adds 2.7M shares (June27)

$Recursion Pharmaceuticals(RXRX.US)$

Mr Long Term

Jun 29 07:30

ColumnsThree AI stocks on the Edge of a Massive surge

Last week, Nvidia $NVIDIA(NVDA.US)$ briefly eclipsed Microsoft $Microsoft(MSFT.US)$ as the world’s most valuable company. The AI chip maker is now worth $3.3 trillion… or roughly the combined value of every residential property in the state of Florida. Shares trade for 50 times forward earnings.
That caused expected hand-wringing on Wall Street.
“We’re not necessarily at peak bubble levels,” said Jonathan Stubbs of Berenberg, a wealth management fi...

BucceesNation

Jun 28 13:20

Recursion Secondary Offering includes Funds for dozens of clinical trials as well as Acquisitions

$Recursion Pharmaceuticals(RXRX.US)$
prospectus of secondary offering resolves two key areas in 4-6 quarters with funds coveing potentially dozensof clinical trials as well as acquisitions.
In May, Recursion also stated that they have future partnerships as well as current partners whose trials include non-dilutive funding as these clical trials progress.
Increased my stake by 15%

Jensen 108

Jun 28 05:17

$Recursion Pharmaceuticals (RXRX.US)$ raising fund kill the willingness & excitement of small investors like myself.

whqqq

Jun 27 21:30

Cramer’s Lightning Round: ‘Hold on to’ Marvell Technology

$Palantir(PLTR.US)$ : ”...It’s one big, giant black box except for the consumer product goods company, so I’m going to have to say there’s other people better to ask.”
$GameStop(GME.US)$ : “GameStop raised enough money off the backs of the apes, the memes, the kitties — whatever — that they can reinvent the company. If they reinvent the company, then you’re absolutely right. They have such a big war chest that they can just close all ...

10baggerbamm

Jun 27 15:38

$Recursion Pharmaceuticals(RXRX.US)$ look at the volume today relative to the past year to date pull a chart the spike is through the roof so you had massive turnover what that means is if you are interested in owning this company and believe in the future you can take an initial position here because anybody that wanted to dump it shit it's as simple as that.

Big bull Salvekar

Jun 27 10:38

Downwar trend follows

$Recursion Pharmaceuticals(RXRX.US)$
Trillion dollar company $NVIDIA(NVDA.US)$ investing few millions is like investing 0.001 cents from 1000$

MomentumPython1337

Jun 27 10:14

i was expecting worse I'm not gonna jinx it but i thought this would crash way down

$Recursion Pharmaceuticals(RXRX.US)$ there were 2 x 1 hr slots where somebody bought several million shares so that's good to see at least it's not just retailers trying to keep a sinking ship afloat there's surprising support forming at the 7 range I thought it would crash all the way down to 6.5 that's the public offering price well I might just be blabbering nonsense and it falls tomorrow to 6.5 either way I'm ...

MomentumPython1337

Jun 27 04:20

sadly i think public offering is not a good sign

$Recursion Pharmaceuticals(RXRX.US)$ it means they're running out of capital and need to raise funds. not a good look for the business. i have a sizeable position nothing too big but it's sizeable about 2% of my portfolio.
the price of 6.50$ is lower than current market price. it is not ridiculous to predict that the market price will gap down to 6.50 in the short term. i guess i will have to see it as a way to average down my cost if i still bel...

102458277 : They are offering much lower price than the current market price . I bought them recently with 9.35.

Report
Reply

Cancel Reply
Jensen 108 : look likes fair value is below current stock price. need to hodl until completed rationalise of stock price

Report
Reply

Cancel Reply
103053687 Jensen 108: is it too late to cut loss?

Report
Reply

Cancel Reply
MomentumPython1337OP 103053687: cut loss is a double edged sword. should reanalyse the business situation and decide if it's a fundamental issue. it could also just be a sign that they want to expand the business and need to spend more in the short term.
long term I'm still bullish on the theme of AI for drug discovery. i have even considered joining their company as I work in this field as well.
once you cut loss you're saying goodbye to the ownership, if it rebounds you may regret. but if you see other better use of your capital then yes cut loss is an option.

Report
Reply

Cancel Reply
10baggerbamm : one has to understand that anytime they invest in a young startup and that's what this is that's in the healthcare of the biotech arena that the one thing that they do constantly they being the companies is burn money and they burn money in an accelerated rate much quicker to a greater extent than a comparable non-healthcare non-drug oriented type of company. so even though one could argue and say this is a software tech company it still falls under the health care biotech drug arena where there's going to be a significant amount of FDA approvals that have to occur throughout its evolutionary period. and as a result there's multiple offerings that happen that's why despite Jensen investing in this company you only want to have your baby toe and sectors like this because they take much longer and you don't want to position yourself where you get frustrated by dilution which is what this is where you lose a significant amount of money short-term which is what's happening and miss the long-term opportunities. we were I guess we don't know so if you have a hundred thousand dollar portfolio $1,000 is all I would put into a company like this with a 5-year horizon

Report
Reply

Cancel Reply

View more comments...

BucceesNation

Jun 27 00:11

Did NVIDIA just double, triple / quadruple down on RXRX?

$Recursion Pharmaceuticals(RXRX.US)$
Interesting that Nvidia owns 3.6% of RXRX and ARK owns 10%. One year ago $NVIDIA(NVDA.US)$ bought 7.7M shares at $6.50 for $50M and now One Year later RXRX has prices an offering at the same price so I‘d wonder IF NVIDIA just became a 10% shareholder in Recursion and who else added to their stakes!

Nvidia's 2024 AGM highlights: Pay packages and new AI market strategies

No comment yet